海外の膵頭十二指腸切除術のベスト医師 — ページ2

テルアビブ医療センターの腫瘍内科入院部門長 – ステファンスキー医師は、複雑な腫瘍症例を専門としています。

• 26 年 の腫瘍学における経験
• 臨床腫瘍学研究の主任研究員
• テルアビブ医療センターで研修
• 内科および腫瘍学の専門医認定

ウィップル手術の専門家として_doctor_234_年以上の経験を持つグリーンバーグ医師は、ソラスキー医療センターの結腸直腸外科部門を率いています。

• 開腹手術および低侵襲手術の両方の専門家
• 結腸直腸外科専門チームを統括
• 複雑な腹部手術を定期的に執刀

イスラエル屈指のウィップル手術専門医であるクラウズナー医師は、膵臓および消化器外科において_doctor_224_年_以上の経験を有しています。

• スラスキー医療センター外科部長
• 大腸、膵臓、消化器の手術を専門とする
• 複雑なウィップル手術における豊富な経験

32 年 肝臓がんおよび膵臓がん専門医 – ベン・ハイム医師は、ソラスキー医療センターにおけるウィップル手術の第一人者です。

• 消化器腫瘍学に注力
• 複雑な膵臓手術を実施
• イスラエルのトップ医療センターに勤務

ゾーリンゲンクリニックの外科部長。膵臓外科および消化器がんの低侵襲手術を専門とする。

• 膵臓がんセンター（Oncocert）コーディネーター
• 最新の外科手術法を導入し、術後の回復を改善
• 腫瘍外科分野における活発な研究者および講師
• ドイツ医師会会員

認定学際的がんセンターの主任医師 – ヴィオラ・フォックス博士は、ウィップル手術を含む腫瘍疾患の高度な治療を専門としています。

• 血液学、腫瘍学、免疫学の認定医
• 分子診断および標的療法の専門家
• 革新的ながん治療のための分子生物学研究に積極的に従事
• ドイツおよびアメリカの腫瘍学会会員

准教授のタフシン・オザトリは、イスティニエ・リヴ大学病院で消化器がんを専門としています。

• 腫瘍学における10年以上の経験
• セルチュク大学医学部で研修
• トルコ国内の複数の腫瘍科で勤務

ムスタファ・セルカン・アレムダル医師は、Medical Park Antalya Hospital Complexにてウィップル手術を専門としており、20 年以上の医療経験を有しています。

• アクデニズ大学医学部にて腫瘍内科の研修を修了
• アクデニズ大学病院にて20 年勤務
• 内科および腫瘍内科の認定医

セリン・カパン教授は一般外科の教授であり、ウィップル手術を含む複雑な処置に精通しています。

• _doctor_10984_年以上の外科経験
• トルコ肝胆膵外科学会会員
• 査読付きジャーナルで50本以上の科学論文を発表
• 腹腔鏡下手術および低侵襲手術を専門とする

高度な腹腔鏡下手術および腫瘍外科における_doctor_7868_年以上の経験 – アル医師は、Büyük Anadolu病院にてウィップル手術のような複雑な処置を専門としています。

• イスタンブール大学チャパ医学部にて腹腔鏡下手術の訓練を受ける
• 腹腔鏡下肥満外科および腫瘍がん外科の高度なトレーニング
• 腹腔鏡下逆流防止手術の技術を専門とする
• 著名なトルコの医療機関の教員メンバー

准教授メフメット・アキフ・アイディンは、メディカルパーク・バフチェリエヴレル病院にてウィップル手術を専門としています。

• 一般外科における_doctor_9753_年以上の経験
• トルコ外科学会および内分泌外科学会の会員
• イスタンブール大学ジェラフパシャ医学部にて研修
• イスタンブールの主要な私立病院に勤務

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

ベン・ブルシ教授は、シェバ・メディカルセンターで消化器腫瘍学を専門とし、ペンシルベニア大学およびMDアンダーソンで高度なトレーニングを受けました。

• マイクロバイオームに基づく革新的ながん治療に注力
• ECOG-ACRINマイクロバイオームワーキンググループの創設者
• メイヨークリニックを含むトップ機関で研修
• Scienceなどの主要ジャーナルで研究を発表
• 膵臓がん検知のための予測モデルを開発

ヤイール・バー博士は、シェバ医療センターの癌センターの副所長であり、胸部腫瘍内科医です。進行非小細胞肺癌の治療において、個別化免疫療法および標的療法を専門としています。分子生物学の博士号（PhD）を取得しており、免疫療法耐性に焦点を当てた研究室を主導しています。

• イスラエル肺癌グループの議長。
• 腫瘍内科および放射線腫瘍学の専門医認定を取得。
• 世界トップ10にランクされるシェバ医療センターで患者を治療。
• 分子・遺伝子プロファイリングを用いて、精密な癌治療計画を作成。

カディール・ディクレ医師は、Büyük Anadolu病院にて、ウィップル手術を含む腫瘍外科を専門としています。

• 胃および胆嚢疾患の治療における専門家
• 代謝外科および肥満外科の熟練者
• 乳腺疾患およびがん治療の経験豊富

チェ・ドクターはソウル国立大学で研修を受け、ピッツバーグ大学でフェローシップを修了し、複雑な膵臓手術を専門としています。

• 国際肝胆膵外科学会会員
• 肝臓および膵臓がん手術を専門
• 韓国膵臓外科学会クラブ所属
• 京都大学医学部で研修

15,000件以上の手術を執刀。TaTMEなどの先駆的な低侵襲技術を導入し、現在世界中で使用されています。

• 複雑な消化器外科手術の専門
• 年間1,000件以上の低侵襲手術を実施
• 欧州外科内視鏡学会会長
• 腹腔鏡下大腸・直腸手術における世界的に有名なパイオニア